Holdings
Penn Capital Special Situations Small Cap Equity Fund
As of May 31, 2026, Penn Capital Special Situations Small Cap Equity Fund reported 81 positions worth US$105M. Largest: Ouster, Inc., Acm Research, Inc. and Mirum Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Ouster, Inc. | 62,038 | US$2.86M | +14,975 | May 31, 2026 |
| Acm Research, Inc. | 31,264 | US$2.71M | +10,248 | May 31, 2026 |
| Mirum Pharmaceuticals, Inc. | 22,757 | US$2.31M | +5,633 | May 31, 2026 |
| Rxo, Inc. | 83,689 | US$2.14M | +335 | May 31, 2026 |
| Constellium Se | 58,423 | US$2M | +6,692 | May 31, 2026 |
| Lumen Technologies, Inc. | 181K | US$1.99M | +37,844 | May 31, 2026 |
| Legence Corp. | 23,627 | US$1.98M | +7,594 | May 31, 2026 |
| Wolfspeed, Inc. | 31,575 | US$1.87M | new | May 31, 2026 |
| Ligand Pharmaceuticals Incorporated | 7,923 | US$1.84M | +285 | May 31, 2026 |
| Caesars Entertainment, Inc. | 59,540 | US$1.73M | +12,409 | May 31, 2026 |